Securities code: 688656 securities abbreviation: Hob Biotech Group Corp.Ltd(688656) Announcement No.: 2022-011 Hob Biotech Group Corp.Ltd(688656)
Announcement on receiving the inquiry letter from Shanghai Stock Exchange
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Hob Biotech Group Corp.Ltd(688656) (hereinafter referred to as “the company”) has received the inquiry letter on the occupation of Hob Biotech Group Corp.Ltd(688656) non operating funds issued by Shanghai Stock Exchange [SSE Ke Chuang Gong Han (2022) 0008] (hereinafter referred to as “the inquiry letter”), and the specific contents of the inquiry letter are as follows:
On February 18, 2022, your company submitted the announcement on self inspection and rectification of non operating fund occupation, which said that on July 23, 2021, the company and its subsidiary Suzhou Hob Biotech Group Corp.Ltd(688656) biomedical Sales Co., Ltd. provided 17 million yuan of inter-bank loan to the related party Suzhou wairun investment management partnership (hereinafter referred to as Suzhou wairun), It is used to supplement and withhold the individual income tax on the equity transfer of Chen Tao, the actual controller of Suzhou wairun, forming the occupation of non operating funds by related parties. All the above loans have been repaid on July 30, 2021. After the post audit, according to article 14.1.1 of the Listing Rules of shares on the science and Innovation Board of Shanghai Stock Exchange, your company is requested to verify and supplement the disclosure of the following matters.
1、 The company is requested to conduct a serious self-examination and explain the specific reasons, main considerations and relevant responsible persons for the formation of the above loans, supplement and disclose the detailed process of early loan and repayment and the specific handling personnel, and provide capital flow and other relevant materials.
2、 Please conduct a comprehensive self-examination and explain whether there are other undisclosed matters such as fund occupation and illegal guarantee that should be disclosed.
3、 Please specify whether the company has established relevant internal control systems such as the use of funds, conduct self-examination and explain whether there are loopholes in the company’s internal control system, problems existing in the implementation and rectification measures to be taken.
4、 The sponsor representative of the company is requested to check the matters mentioned in the above questions and express opinions one by one; It also conducts special verification on the capital transactions between the company and its controlling shareholders, actual controllers and other related parties and the implementation of internal control mechanism, and issues special verification opinions.
5、 Ask the company’s annual audit accountant to check the matters mentioned in the above questions and express opinions one by one; In the audit of the company’s annual financial and accounting report, the company focused on the capital transactions between the company and its controlling shareholders, actual controllers and other related parties, as well as the implementation of internal control mechanism, and issued special instructions.
All directors, supervisors, senior managers, controlling shareholders and actual controllers of your company shall attach great importance to and implement the requirements of this inquiry letter, conduct comprehensive self-examination and actively take corrective measures, timely fulfill the obligation of information disclosure, and safeguard the legitimate rights and interests of listed companies and minority shareholders. For the non operational occupation of funds of listed companies by related parties, the exchange will initiate disciplinary procedures and seriously hold the relevant responsible persons accountable in accordance with laws and regulations.
Please disclose this inquiry letter on February 19, 2022 and your reply to this inquiry letter on February 24, 2022.
The company will actively respond to the questions involved in the inquiry letter and fulfill the obligation of information disclosure in time according to the requirements of the management department of science and Innovation Board of Shanghai Stock Exchange. Please pay attention to the company’s announcement and pay attention to investment risks.
It is hereby announced.
Hob Biotech Group Corp.Ltd(688656)
Board of directors
February 19, 2022
